Annual Total Liabilities
$193.98 M
-$2.51 M-1.28%
December 31, 2023
Summary
- As of February 20, 2025, ADMA annual total liabilities is $193.98 million, with the most recent change of -$2.51 million (-1.28%) on December 31, 2023.
- During the last 3 years, ADMA annual total liabilities has risen by +$74.55 million (+62.43%).
- ADMA annual total liabilities is now -1.28% below its all-time high of $196.49 million, reached on December 31, 2022.
Performance
ADMA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$158.73 M
-$29.40 M-15.63%
September 30, 2024
Summary
- As of February 20, 2025, ADMA quarterly total liabilities is $158.73 million, with the most recent change of -$29.40 million (-15.63%) on September 30, 2024.
- Over the past year, ADMA quarterly total liabilities has stayed the same.
- ADMA quarterly total liabilities is now -20.70% below its all-time high of $200.17 million, reached on September 30, 2022.
Performance
ADMA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ADMA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.3% | 0.0% |
| 3 y3 years | +62.4% | -19.2% |
| 5 y5 years | +180.7% | -19.2% |
ADMA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.3% | +43.6% | -20.7% | +17.5% |
| 5 y | 5-year | -1.3% | +92.3% | -20.7% | +57.3% |
| alltime | all time | -1.3% | >+9999.0% | -20.7% | >+9999.0% |
ADMA Biologics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $158.73 M(-15.6%) |
| Jun 2024 | - | $188.13 M(-4.6%) |
| Mar 2024 | - | $197.17 M(+1.6%) |
| Dec 2023 | $193.98 M(-1.3%) | $193.98 M(-1.8%) |
| Sep 2023 | - | $197.56 M(+0.7%) |
| Jun 2023 | - | $196.26 M(+0.6%) |
| Mar 2023 | - | $195.13 M(-0.7%) |
| Dec 2022 | $196.49 M(+45.5%) | $196.49 M(-1.8%) |
| Sep 2022 | - | $200.17 M(+9.7%) |
| Jun 2022 | - | $182.53 M(+0.8%) |
| Mar 2022 | - | $181.10 M(+34.1%) |
| Dec 2021 | $135.08 M(+13.1%) | $135.08 M(-0.6%) |
| Sep 2021 | - | $135.86 M(+12.1%) |
| Jun 2021 | - | $121.22 M(-1.6%) |
| Mar 2021 | - | $123.16 M(+3.1%) |
| Dec 2020 | $119.42 M(+18.4%) | $119.42 M(+0.7%) |
| Sep 2020 | - | $118.60 M(+3.4%) |
| Jun 2020 | - | $114.66 M(+0.4%) |
| Mar 2020 | - | $114.19 M(+13.2%) |
| Dec 2019 | $100.90 M(+46.0%) | $100.90 M(-0.8%) |
| Sep 2019 | - | $101.66 M(+5.5%) |
| Jun 2019 | - | $96.37 M(+41.5%) |
| Mar 2019 | - | $68.08 M(-1.5%) |
| Dec 2018 | $69.11 M(+2.1%) | $69.11 M(-0.0%) |
| Sep 2018 | - | $69.14 M(+4.8%) |
| Jun 2018 | - | $65.99 M(-3.1%) |
| Mar 2018 | - | $68.11 M(+0.6%) |
| Dec 2017 | $67.69 M | $67.69 M(+13.1%) |
| Sep 2017 | - | $59.82 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $56.96 M(+100.9%) |
| Mar 2017 | - | $28.35 M(+0.7%) |
| Dec 2016 | $28.14 M(+22.9%) | $28.14 M(+1.8%) |
| Sep 2016 | - | $27.65 M(-0.6%) |
| Jun 2016 | - | $27.83 M(+20.7%) |
| Mar 2016 | - | $23.05 M(+0.7%) |
| Dec 2015 | $22.89 M(+8.9%) | $22.89 M(-0.1%) |
| Sep 2015 | - | $22.91 M(+13.0%) |
| Jun 2015 | - | $20.28 M(-1.1%) |
| Mar 2015 | - | $20.50 M(-2.5%) |
| Dec 2014 | $21.01 M(+101.9%) | $21.01 M(+31.0%) |
| Sep 2014 | - | $16.04 M(+3.0%) |
| Jun 2014 | - | $15.58 M(-2.9%) |
| Mar 2014 | - | $16.05 M(+54.2%) |
| Dec 2013 | $10.41 M(+69.7%) | $10.41 M(+10.3%) |
| Sep 2013 | - | $9.44 M(+5.3%) |
| Jun 2013 | - | $8.96 M(+20.8%) |
| Mar 2013 | - | $7.42 M(+21.0%) |
| Dec 2012 | $6.13 M(>+9900.0%) | $6.13 M(+279.0%) |
| Sep 2012 | - | $1.62 M(+31.7%) |
| Jun 2012 | - | $1.23 M(-2.4%) |
| Mar 2012 | - | $1.26 M(>+9900.0%) |
| Dec 2011 | - | $5300.00(-45.9%) |
| Sep 2011 | - | $9800.00(0.0%) |
| Jun 2011 | $9800.00(-21.0%) | $9800.00(+69.0%) |
| Mar 2011 | - | $5800.00(+20.8%) |
| Dec 2010 | - | $4800.00(-61.3%) |
| Jun 2010 | - | $12.40 K |
| Jun 2010 | $12.40 K | - |
FAQ
- What is ADMA Biologics annual total liabilities?
- What is the all time high annual total liabilities for ADMA Biologics?
- What is ADMA Biologics annual total liabilities year-on-year change?
- What is ADMA Biologics quarterly total liabilities?
- What is the all time high quarterly total liabilities for ADMA Biologics?
- What is ADMA Biologics quarterly total liabilities year-on-year change?
What is ADMA Biologics annual total liabilities?
The current annual total liabilities of ADMA is $193.98 M
What is the all time high annual total liabilities for ADMA Biologics?
ADMA Biologics all-time high annual total liabilities is $196.49 M
What is ADMA Biologics annual total liabilities year-on-year change?
Over the past year, ADMA annual total liabilities has changed by -$2.51 M (-1.28%)
What is ADMA Biologics quarterly total liabilities?
The current quarterly total liabilities of ADMA is $158.73 M
What is the all time high quarterly total liabilities for ADMA Biologics?
ADMA Biologics all-time high quarterly total liabilities is $200.17 M
What is ADMA Biologics quarterly total liabilities year-on-year change?
Over the past year, ADMA quarterly total liabilities has changed by $0.00 (0.00%)